Protagonist Therapeutics (PTGX) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of$0.50. This compares to earnings of $3.26 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 62$0.06 per share when it actually produced earnings of $1.98, delivering a surprise of 3,200%.Over the last four qu ...